Proteome Sciences plc (AIM:PRM)
London
· Delayed Price · Currency is GBP · Price in GBX 2.900
+0.150 (5.45%)
Apr 17, 2025, 4:35 PM GMT+1
Proteome Sciences Revenue
In the year 2024, Proteome Sciences had annual revenue of 4.89M GBP, down -2.80%. Proteome Sciences had revenue of 2.67M in the half year ending December 31, 2024, a decrease of -41.15%.
Revenue
4.89M
Revenue Growth
-2.80%
P/S Ratio
1.75
Revenue / Employee
139.63K
Employees
35
Market Cap
8.56M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.89M | -141.00K | -2.80% |
| Dec 31, 2023 | 5.03M | -2.75M | -35.37% |
| Dec 31, 2022 | 7.78M | 2.65M | 51.69% |
| Dec 31, 2021 | 5.13M | 376.00K | 7.91% |
| Dec 31, 2020 | 4.75M | 97.00K | 2.08% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |
Proteome Sciences News
- 7 weeks ago - AIM Market Roundup: Proteome Sciences, UKRProduct, Staffline - The Armchair Trader